Conference Coverage

Evaluation of Cortical Lesions Could Improve Diagnosis of MS


 

References

At follow-up, 65 patients (90%) had clinically and/or radiologically definite MS. The sensitivity of all criteria was high (McDonald 2005, 83%; McDonald 2010, 92%; Filippi 2010, 80%). Specificity of Filippi 2010 was higher (67%) compared with the others (50% for McDonald 2005 and 2010). The accuracy of all criteria was high (McDonald 2005, 81%; McDonald 2010, 89%; Filippi 2010, 79%).

“The detection of cortical lesions in vivo using MRI should be considered in future clinical trials,” Dr. Preziosa said.

—Glenn S. Williams

Pages

Recommended Reading

Peter Chin, MD
MDedge Neurology
FDA accepting comments on draft guidelines on compounding law
MDedge Neurology
Hemophilia drugs top Medicaid spending per prescription
MDedge Neurology
Is Biotin an Effective Treatment for Progressive MS?
MDedge Neurology
Abatacept fails to provide benefit in relapsing-remitting MS
MDedge Neurology
Harold Moses Jr, MD
MDedge Neurology
Cognitive impairment predicts worsening multiple sclerosis
MDedge Neurology
Abatacept Fails to Provide Benefits in Relapsing MS
MDedge Neurology
Multiple Sclerosis Is Associated With Changes in the Gut Microbiome
MDedge Neurology
Th17 Cells Are Activated in the Gut of Patients With MS
MDedge Neurology